1. Dubey JP. Toxoplasmosis of animals and humans: CRC press; 2016. 2. Montoya J, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363(9425):1965-76. 3. Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bulletin of the World Health Organization. 2013;91:501-8. 4. Fenta DA. Seroprevalence of Toxoplasma gondii among pregnant women attending antenatal clinics at Hawassa University comprehensive specialized and Yirgalem General Hospitals, in Southern Ethiopia. BMC Infectious Diseases. 2019;19(1):1056-64. 5. Paul E, Kiwelu I, Mmbaga B, Nazareth R, Sabuni E, Maro A, et al. Toxoplasma gondii seroprevalence among pregnant women attending antenatal clinic in Northern Tanzania. Tropical medicine and health. 2018;46(1):39-47. 6. Abdoli A, Dalimi A, Arbabi M, Ghaffarifar F. Neuropsychiatric manifestations of latent toxoplasmosis on mothers and their offspring. The Journal of Maternal-Fetal & Neonatal Medicine. 2014;27(13):1368-74. 7. Liu Q, Wang Z-D, Huang S-Y, Zhu X-Q. Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasites & vectors. 2015;8(1):292-306. 8. Gelaye W, Kebede T, Hailu A. High prevalence of anti-toxoplasma antibodies and absence of Toxoplasma gondii infection risk factors among pregnant women attending routine antenatal care in two Hospitals of Addis Ababa, Ethiopia. International Journal of Infectious Diseases. 2015;34:41-5. 9. Daryani A, Sarvi S, Aarabi M, Mizani A, Ahmadpour E, Shokri A, et al. Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta tropica. 2014;137:185-94. 10. Malary M, Hamzehgardeshi Z, Moosazadeh M, Afshari M, Ahmadi I, Moghaddasifar I, et al. Seroprevalence of Toxoplasma gondii infection among Iranian pregnant women: a systematic review and meta-analysis. Eastern Mediterranean Health Journal. 2018;24(5):488-96. 11. Ebadi P, Solhjoo K, Bagheri K, Eftekhar F. Seroprevalence of toxoplasmosis in womwen with recurrent spontaneous abortion. International Journal of Reproductive Biomedicine. 2011;9(1):32-7. (Persian.( 12. Azadi T, Darabi M, Sayehmiri F, Sayehmiri K. Investigating the Prevalence of Toxoplasmosis in Iranian Pregnant Women: A Systematic Review and Meta-Analysis. scientific journal of ilam university of medical sciences. 2017;25(1):148-58. (Persian.( 13. Sharbatkhori M, Moghaddam YD, Pagheh AS, Mohammadi R, Mofidi HH, Shojaee S. Seroprevalence of Toxoplasma gondii infections in pregnant women in Gorgan city, Golestan province, Northern Iran-2012. Iranian Journal of Parasitology. 2014;9(2):181-7. 14. Teimouri A, Rahimi Esboei B, Mousavi P, Taghavi M. Sero-prevalence of Toxoplasma Gondii Infection among Women in First Trimester of Pregnancy of Women in Razavi-Khorasan Province. J Neyshabur Univ Med Sci. 2016;3(4): 10-18. (Persian.( 15. Zalei B, Pourmand D, Bilvayea S, Jalilzadeh Hamidi H. Seroepidemiology of toxoplasmosis in pregnant women referred to reference laboratory in Kermanshah, 2014-2015. 2016:125-31. (Persian.( 16. Matin S, Shahbazi G, Namin ST, Moradpour R, Feizi F, Piri-dogahe H. Comparison of placenta PCR and maternal serology of aborted women for detection of Toxoplasma gondii in Ardabil, Iran. The Korean journal of parasitology. 2017;55(6):607-12. 17. Iddawela D, Vithana SMP, Ratnayake C. Seroprevalence of toxoplasmosis and risk factors of Toxoplasma gondii infection among pregnant women in Sri Lanka: a cross sectional study. BMC public health. 2017;17(1):930-6. 18. Elfadaly HA, Hassanan N, Shaapan RM, Hassanain MA, Barakat AM, Abdelrahman KA. Molecular detection and genotyping of Toxoplasma gondii from Egyptian isolates. Asian J Epidemiol. 2017;10:37-44. 19. Alghamdi J, Elamin MH, Alhabib S. Prevalence and genotyping of Toxoplasma gondii among Saudi pregnant women in Saudi Arabia. Saudi Pharmaceutical Journal. 2016;24(6):645-51. 20. Hernández-Cortazar IB, Acosta-Viana KY, Guzman-Marin E, Segura-Correa JC, Ortega-Pacheco A, Carrillo-Martínez JR, et al. Toxoplasma gondii in women with recent abortion from Southern Mexico. Asian Pacific Journal of Tropical Disease. 2016;6(3):193-8. 21. Laboudi M. Review of toxoplasmosis in Morocco: seroprevalence and risk factors for Toxoplasma infection among pregnant women and HIV-infected patients. The Pan African medical journal. 2017;27:269-76. 22. Hazrati Tappeh K, Mousavi SJ, Bouzorg Omid A, Alinejad V, Alizadeh H. Seroepidemiology and risk factors of toxoplasmosis in pregnant women in Urmia city. The Journal of Urmia University of Medical Sciences. 2015;26(4):296-302. (Persian.( 23. Kalantari N, Ghaffari S, Bayani M, Agapour R, Zeinalzadeh M, Gavipanjeh F, et al. Serological study of toxoplasmosis in pregnant women in Babol, northern Iran 2012-2013. scientific journal of ilam university of medical sciences. 2014;22(4):102-8. (Persian. ( 24. Durukan H, Çevikoğlu MK. Retrospective Evaluation of the Seropositivity Rate of Toxoplasmosis and Clinical Results in Pregnant Women That were Admitted to a Tertiary Health Institution Between 2012 and 2017 in Turkey. Turkiye parazitolojii dergisi. 2019;43(3):106-10. 25. Frimpong C, Makasa M, Sitali L, Michelo C. Seroprevalence and determinants of toxoplasmosis in pregnant women attending antenatal clinic at the university teaching hospital, Lusaka, Zambia. BMC infectious diseases. 2017;17(1):10-8. 26. Shirdel S, Sharbatkhori M, Pagheh AS, Dadimoghadam Y, Soosaraie M, Gholami S. Seroepidemiology of Toxoplasma gondii Infection in Pregnant Women and Risk Factors of the Disease in Golestan Province, Iran. Journal of Mazandaran University of Medical Sciences. 2017;27(152):63-71. (Persian.( 27. Kamal AM, Ahmed AK, Abdellatif MZ, Tawfik M, Hassan EE. Seropositivity of toxoplasmosis in pregnant women by ELISA at Minia University Hospital, Egypt. The Korean journal of parasitology. 2015;53(5):605-10. 28. Shieh M, Didehdar M, Hajihossein R, Ahmadi F, Eslamirad Z. Toxoplasmosis: Seroprevalence in pregnant women, and serological and molecular screening in neonatal umbilical cord blood. Acta tropica. 2017;174:38-44. 29. Mizani A, Alipour A, Sharif M, Sarvi S, Amouei A, Shokri A, et al. Toxoplasmosis seroprevalence in Iranian women and risk factors of the disease: a systematic review and meta-analysis. Trop Med Health. 2017;45:7-20. 30. Hamidi M, Khulojini M, Azizian R, Bashiri H, Ahanchian A, Babanejad M, et al. Seroprevalence of toxoplasmosis among women referring to Shahid Beheshti Hospital, Hamadan, Iran. Novelty in Biomedicine. 2015;3(1):1-5. 31. Fallahizadeh S, Jelowdar A, Kazemi F, Cheraghian B. Seroprevalence of anti-toxoplasma IgG and IgM among pregnant women of Shush county, southwest of Iran. Int J Infect. 2018;5(2):e12192. 32. Foroutan-Rad M, Khademvatan S, Majidiani H, Aryamand S, Rahim F, Malehi AS. Seroprevalence of Toxoplasma gondii in the Iranian pregnant women: a systematic review and meta-analysis. Acta tropica. 2016;158:160-9 33. Hung C-S, Su H-W, Lee Y-L, Weng H-W, Wang Y-C, Naito T, et al. Seroprevalence, seroconversion, and risk factors for toxoplasmosis among pregnant women in Taipei, Taiwan. Japanese journal of infectious diseases. 2015;68(4):312-7.
مجله علوم پزشکی پارس
)